Annular atrophic lichen planus induced by anti‐HER2 antibodies
Sign Up to like & getrecommendations! Published in 2020 at "Australasian Journal of Dermatology"
DOI: 10.1111/ajd.13501
Abstract: Pertuzumab and trastuzumab are monoclonal antibody inhibitors targeting human epidermal growth factor receptor 2 (HER‐2) and are increasingly being utilised in the management of HER2‐positive breast cancer, having been demonstrated to improve progression‐free survival in… read more here.
Keywords: lichen planus; induced anti; planus induced; atrophic lichen ... See more keywords